Hyperlipidemia in children with HIV infection: an emerging problem.

about

Managing dyslipidemia in HIV/AIDS patients: challenges and solutions Longitudinal assessment of metabolic abnormalities in adolescents and young adults with HIV-infection acquired perinatally or in early childhood

P2860

Q28084941-B7295C65-894B-4AB4-A4A3-BA788DB82066 Q34495072-0959995E-E878-4880-9A64-BF655C43B61C

P2860

Hyperlipidemia in children with HIV infection: an emerging problem.

Item

http://www.wikidata.org/entity/Q35696547

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Hyperlipidemia in children with HIV infection: an emerging problem.

@ast

Hyperlipidemia in children with HIV infection: an emerging problem.

@en

type

Item

label

Hyperlipidemia in children with HIV infection: an emerging problem.

@ast

Hyperlipidemia in children with HIV infection: an emerging problem.

@en

prefLabel

Hyperlipidemia in children with HIV infection: an emerging problem.

@ast

Hyperlipidemia in children with HIV infection: an emerging problem.

@en

P1476

Hyperlipidemia in children with HIV infection: an emerging problem.

@en

P2093

Colleen Hadigan

http://www.w3.org/2001/XMLSchema#string

Daniel Kamin

http://www.w3.org/2001/XMLSchema#string

P2860

Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey.

Hyperlipidemia in children and adolescents.

Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.

Role of cytokines in inducing hyperlipidemia.

Lipodystrophy in HIV-infected children is associated with high viral load and low CD4+ -lymphocyte count and CD4+ -lymphocyte percentage at baseline and use of protease inhibitors and stavudine.

HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemia.

Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance.

Lipodystrophy syndrome in human immunodeficiency virus-infected children.

Mitochondrial functionality and mitochondrial DNA content in lymphocytes of vertically infected human immunodeficiency virus-positive children with highly active antiretroviral therapy-related lipodystrophy.

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.

P304

143-150

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14779072.1.1.143

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15030304

http://www.w3.org/2001/XMLSchema#string

Hyperlipidemia in children with HIV infection: an emerging problem.

about

P2860

P2860

Hyperlipidemia in children with HIV infection: an emerging problem.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698